| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2851587 | American Heart Journal | 2009 | 10 Pages |
Abstract
Overall, neither BNP nor NT-proBNP accurately discriminated subjects with LVH or LVSD in this predominately young and healthy population-based cohort. However, among high-risk men, NT-proBNP performed slightly better than BNP and comparably with other routinely used screening tests such as prostate-specific antigen measurement for prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
James A. MD, Darren K. MD, MHSc, Amit MD, MSc, Sandeep R. MD, MPH, Sabina A. MPH, Torbjorn MD, PhD, MPH, Mark H. MD, MSc,